Further processing options
The JAK Inhibitor, INCB018424, Demonstrates Durable and Marked Clinical Responses in Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post...
Saved in:
Journal Title: | Blood |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , |
In: | Blood, 112, 2008, 11, p. 1762-1762 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Hematology
|
Subjects: |